S020 New Innovations in Dermatology: What Devices You Will Be Using in the Next 1-5 Years
DESCRIPTION
This session will be devoted towards examining the cutting-edge changes in the practice of medical and aesthetic dermatology s in terms of treatments and technologies. This session will emphasize current and forward-looking “game changers” that will transform the delivery of dermatologic care for the benefit of our patients featuring the world leaders creating this innovation.
LEARNING OBJECTIVES
Describe future innovations in the treatment of medical and aesthetic dermatology new treatments in dermatology.
Explain the scientific foundation for new innovations in medical and aesthetic dermatology
Predict new devices to become routine parts of clinical practice in the next 1-5 years.
DIRECTOR
Mathew M. Avram, MD, JD, FAAD
SPEAKERS
Richard Rox Anderson, MD, FAAD
Marc R. Avram, MD, FAAD
Roy G. Geronemus, MD, FAAD
Jeremy Green, MD, FAAD
John Harris, MD, PhD, FAAD
Dieter Manstein, MD, PhD
DISCLOSURES
Richard Rox Anderson, MD, FAAD
Accure Acne Inc. – Advisory Board(Stock); AVAVA, LLC – Advisory Board(Stock); Blossom Innovations, LLC – Founder(Stock); Brixton Biosciences – Founder(Stock); Cytrellis Biosystems, Inc – Advisory Board(Stock); Massachusetts General Hospital – Employee(Patent royalties or other compensation for Intellectual Property Rights); Sofregen Medical, Inc. – Consultant(Stock Options);
Marc R. Avram, MD, FAAD
Lumenis Be Ltd. – Consultant (1099 relationship)(Honoraria);
Mathew M. Avram, MD, JD, FAAD
Allergan, Inc – Consultant (1099 relationship)(Fees); Cytrellis Biosystems, Inc – Consultant(Stock), Consultant(Stock Options); La Jolla NanoMedical – Consultant (1099 relationship)(Stock Options); Sofwave – Consultant (1099 relationship)(Stock Options);
Roy G. Geronemus, MD, FAAD
Allergan, Inc – Investigator(Grants/Research Funding); Allergan, Inc. – Advisory Board(Grants/Research Funding); ArchiMedus – Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); Lutronic – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); New York Stem Cell Foundation – Investigator(Grants/Research Funding); Syneron Candela – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding);
Jeremy Green, MD, FAAD
Allergan, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Amplifica – Investigator(Grants/Research Funding); Appiell Inc. – Advisory Board(Stock Options); Candesant Biomedical, Inc. – Stockholder(Stock); Croma-Pharma GmbH Austria – Investigator(Grants/Research Funding); Evolus, Inc. – Investigator(Grants/Research Funding), Speaker(Honoraria); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding), Speaker(Honoraria); Galderma USA – Advisory Board(Honoraria); Ipsen – Advisory Board(Honoraria), Investigator(Grants/Research Funding); L'Oréal Research and Innovation – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Merz Aesthetics – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Nordberg Medical – Investigator(Grants/Research Funding); Revance Therapeutics, Inc. – Investigator(Grants/Research Funding); Revelle Aesthetics, Inc. – Advisory Board(Stock Options); Rion Aesthetics – Speaker(Honoraria); Silk Medical Aesthetics Inc. – Investigator(Grants/Research Funding); Sinclair Pharma – Investigator(Grants/Research Funding); VeraDermics Inc. – Investigator(Grants/Research Funding);
John Harris, MD, PhD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Aclaris Therapeutics Inc. – Investigator(Grants/Research Funding); Aclaris Therapeutics, Inc. – Consultant(Fees); Aldena Therapeutics – Consultant(Fees), Founder(Stock); Almirall – Consultant(Fees); Alys Pharmaceuticals – Founder(Salary), Stockholder Private Company(Fees); Bain Capital – Consultant (1099 relationship)(Fees); Barinthus Biotherapeutics North America, Inc. – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Boxer Capital Management, LLC – Consultant (1099 relationship)(Fees); Cour Pharmaceuticals – Investigator(Grants/Research Funding); Dren Bio – Investigator(Grants/Research Funding); Granular Therapeutics – Consultant(Fees); Incyte Corporation – Investigator(Grants/Research Funding); Klirna Biotech, Inc. – Founder(Stock); Klirna Therapeutics – Founder(Stock); Leo Pharma Inc – Investigator(Grants/Research Funding); NexImmune – Investigator(Grants/Research Funding); Nira Biosciences, Inc. – Consultant(Fees), Founder(Stock); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Villaris Therapeutics, Inc – Founder(Stock), Investigator(Grants/Research Funding); Vimela – Consultant(Honoraria), Stockholder(Stock); Vividion Therapeutics – Consultant (1099 relationship)(Fees);
Dieter Manstein, MD, PhD
AVAVA, LLC – Consultant(Honoraria); Avava, LLC – Stockholder(Stock); Blossom Innovations, LLC – Stockholder(Stock); GME German Medical Engineering GmbH – Stockholder(Stock); R2 Dermatology, Inc. – Consultant(Honoraria), Other(Patent royalties or other compensation for Intellectual Property Rights); Soltego – Other(Stock); Syneron Candela – Other(Patent royalties or other compensation for Intellectual Property Rights); Zeltiq Aesthetics – Other(Patent royalties or other compensation for Intellectual Property Rights);